Navigation Links
Elasticity imaging identifies cancers and reduces breast biopsies

study 166 lesions identified and scheduled for biopsy in 99 patients. Lesions were measured for the largest length on both the standard ultrasound image and the elasticity image. Lesions where the elasticity image was smaller than the standard image were characterized as benign, and lesions where the elasticity image was larger were characterized as malignant.

Ultrasound-guided biopsies were performed on 80 patients with 123 lesions. Biopsy showed that elasticity imaging correctly identified all 17 malignant lesions and 105 of 106 benign lesions, for a sensitivity of 100 percent and a specificity of 99 percent.

“Our ability to find lesions in the breast has increased significantly over the last 10 years but at the expense of an increased number of biopsies,?Dr. Barr said. “This technique could significantly reduce the number of biopsies and increase the confidence of women that a detected lesion is truly benign.?

He anticipates that elasticity imaging will also help in detecting cancers, but did not evaluate that capability for this study. Dr. Barr and colleagues are planning to expand their research in an international, multicenter trial beginning in January 2007.
'"/>

Source:Radiological Society of North America


Page: 1 2

Related biology news :

1. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
2. Duke engineers develop new 3-D cardiac imaging probe
3. Confocal imaging promises early detection of skin cancer
4. Newer imaging techniques may lead to over-treatment
5. Researchers use 3-D imaging system to unveil swimming behavior of microscopic plankton
6. Microscopic brain imaging in the palm of your hand
7. New imaging technology shown to detect pancreatic inflammation in type 1 diabetes
8. Purdues gold nanorods brighten future for medical imaging
9. PET imaging reveals the immune system at work
10. New technique puts brain-imaging research on its head
11. T-rays: New imaging technology spotlighted by American Chemical Society

Post Your Comments:
(Date:11/5/2009)...n, Conn.Researchers at Yale University have develo...ody,s immune response to HIV and HIV-infected cell...ings, published online in the Journal of the Amer...eutic approaches for these diseases. , The mole...ing HIV" (ARM-H) and "antibody-recruiting molecule...
(Date:11/4/2009)...PHIA Although scientists are reluctant to officia...d, evidence continues to grow about its protective...ed in Cancer Prevention Research , a journal of t... suggests some reduction in oral cancer. , Vass...ine in the Department of Thoracic/Head and Neck Me...
(Date:11/4/2009)...affic corridors in the cities of Long Beach and Ri...on of preventable childhood asthma, and the true i...isease has likely been underestimated, according t...rnia (USC). , The study, which appears in an on...alth , estimated that nine percent of all childhoo...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2USC study finds big air pollution impacts on local communities 2Any Day OK for Heart Bypass Surgery 58127 1Any Day OK for Heart Bypass Surgery 58127 2Data Strategy Invited to Become a Member of VMware 26apos 3Bs Partner Technical Advisory Board 28PTAB 29 58123 1Data Strategy Invited to Become a Member of VMware 26apos 3Bs Partner Technical Advisory Board 28PTAB 29 58123 2Healthcare Breach Notification Rules Take Effect 3B ID Experts Offers Complimentary Tool to Measure Organizations Breach Index 58119 1Healthcare Breach Notification Rules Take Effect 3B ID Experts Offers Complimentary Tool to Measure Organizations Breach Index 58119 2Healthcare Breach Notification Rules Take Effect 3B ID Experts Offers Complimentary Tool to Measure Organizations Breach Index 58119 3
...reat idea or invention but don,t know where to tur...ing day of four workshops for first-time entrepren...Center and the Alumni Association of NJIT. Set fo...30 a.m. 3 p.m., the event will feature many oppor...ch that dream. , "I Have an Idea, Now What?" is...
...ase, MDCigarette smoking during pregnancy is assoc...ernal and fetal thyroid function, according to a n... Society,s Journal of Clinical Endocrinology & Me...f cigarette smoking on thyroid function of two gro... in the first trimester and the other in the third...
...lle, NY, January 12, 2009The Academy of Breastfeed...ite, Facebook, would be well advised to review its...rs. Such a policy perpetuates the notion that brea... from public viewing, a misguided and antiquated c...It further perpetuates the idea that formula feedi...
Other Biology News:Entrepreneurs wanted for NJIT workshops about how to launch a business 2
(Date:11/6/2009)...f., Nov. 6 Intarcia Therapeutics, ... 650 (DUROS® continuous delivery of exenatide...the Ninth Annual Diabetes Technology Meeting in Sa...com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, Co...CA 650 Lowers Plasma Glucose, HbA1c and Reduces We...
(Date:11/5/2009)...olo., Nov. 5 The endangered black-...stern U.S. This rare carnivore feeds on prairie d...ague and often entire population die-offs in towns...) has implemented a ferret breeding program and ha...ir formerly native habitat. Unfortunately, plague...
(Date:11/5/2009)...ll on Thursday, November 5, 2009 at 4:30 p.m. East...PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals,...I ) today reported unaudited financial results for... 30, 2009 and reviewed the Company,s highlights fo...onsolidated results reflect the operations of Onco...
(Date:11/5/2009)...exas, Nov. 5 Wound Manag...that it has entered into a Letter of Intent to pur...lth Technologies, Inc. (OTC Bulletin Board: VHGI)....in cash and debt, 4,000,000 shares of WNDM and a r... the Veriscrip technology being acquired from VHGI...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...sia/ -- Simcere Pharmaceutical Group,("Simcere" or...urer and supplier,of branded generic and innovativ...ed financial results for the quarter ended March 3...creased to RMB442.5 million (US$64.8 million) for ...lion for the corresponding, period in 2008, ...
...ls announces it has signed an agreement with HUYA ... enabling and accelerating global codevelopment of...ginating in China. , , Through this agreement, S...omprehensive Chinese molecule portfolio, focusing ...ea. As some of these molecules are already in adv...
...oratories, Inc., an emerging specialty pharmaceuti...ausea and vomiting (OINV) in opioid pharmaceutical... Exploratory Bioequivalence Study on CL-108, Charl...ising data on our immediate-release low-dose antie...icer at Charleston Laboratories, "and confirm our ...
Other Biology Technology:Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 2Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 3Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 4Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 5Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 6Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 7Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 8Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 9Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 10Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 11Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China 2Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China 3Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108 2
Rabbit Anti-Human DNase II Polyclonal Antibody, Unconjugated from Calbiochem
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Collagen I 60 mm Culture Dishes from BD Biosciences - Discovery Labware
Corning C ulture Dishes,100X20 mm,55Cm2,Sterile,6-Pack Carrier (6Pks Of 10 Dishes) from Sigma-Aldrich
Biology Products: